Showing results (11-20 of 73) with videos related to
Sort By:
Pageof 8
Journal of Gastroenterology|October 18, 2007
Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversionKiyoaki Ito, Yasuhito Tanaka, Michio Kato, et al.World Journal of Gastroenterology|July 20, 2004
Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in HawaiiMayumi Sakurai, Fuminaka Sugauchi, Naoky Tsai, et al.Intervirology|April 9, 2002
Liver transplantation-associated de novo hepatitis B virus infection: application of molecular evolutionary analysisFuminaka Sugauchi, Etsuro Orito, Tomoyoshi Ohno, et al.Journal of Clinical Microbiology|December 19, 2008
Abbott RealTime hepatitis C virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV assays for prediction of sustained virological response to pegylated interferon and ribavirin in chronic hepatitis C patientsKentaro Matsuura, Yasuhito Tanaka, Izumi Hasegawa, et al.The Journal of Infectious Diseases|April 28, 2010
Positive selection of core 70Q variant genotype 1b hepatitis C virus strains induced by pegylated interferon and ribavirinFuat Kurbanov, Yasuhito Tanaka, Kentaro Matsuura, et al.Journal of Virology|July 31, 2009
A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype JKanako Tatematsu, Yasuhito Tanaka, Fuat Kurbanov, et al.The Journal of Infectious Diseases|May 17, 2003
Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in JapanYasuhito Tanaka, Takahisa Furuta, Seiji Suzuki, et al.Journal of Medical Virology|January 26, 2011
Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysisMasayuki Kurosaki, Naoya Sakamoto, Manabu Iwasaki, et al.Journal of Clinical Microbiology|August 16, 2013
Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearanceNoboru Shinkai, Kentaro Matsuura, Fuminaka Sugauchi, et al.Journal of Gastroenterology and Hepatology|September 17, 2003
Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infectionSeiji Suzuki, Yasuhito Tanaka, Etsuro Orito, et al.Pageof 8